SpyGlass Pharma, Inc. SEC filings SGP
SpyGlass Pharma, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jun 5, 2019. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 17, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 13, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4/A | Filing | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 10, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
Showing 60 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SGP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1778922
- Former names
- SpyGlassPharma, Inc. (until Jun 5, 2025); SpyGlass Ophthalmics, Inc. (until Jan 5, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.